SCHEMBL5318756

SCHEMBL5318756

COC(=O)C=Cc1nn(Cc2ccc(F)cc2F)c2cc(S(C)(=O)=O)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
PTGS2 P35354 5/20 0.39
PTGS1 P23219 4/20 0.39
ENPP2 Q13822 1/20 0.37
KCNK3 O14649 5/20 0.36
PTGDR2 Q9Y5Y4 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C8 P10632 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2A6 P11509 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2B6 P20813 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTGDR Q13258 1/20 0.35
PTGER1 P34995 2/20 0.34
GSK3B P49841 1/20 0.33
BACE1 P56817 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5318755 1.00 RXRA (0.40) RXRANR1H2NR1H3PTGS2PTGS1
SCHEMBL5321861 0.91 ENPP2 (0.40) ENPP2
SCHEMBL5321858 0.91 ENPP2 (0.40) ENPP2
SCHEMBL5317819 0.91 ENPP2 (0.41) NR1H2NR1H3PTGS2ENPP2PTGDR2
SCHEMBL5317823 0.91 ENPP2 (0.41) NR1H2NR1H3PTGS2ENPP2PTGDR2
SCHEMBL5319279 0.90 RXRA (0.41) RXRANR1H2NR1H3PTGS2PTGS1
SCHEMBL5319276 0.90 RXRA (0.41) RXRANR1H2NR1H3PTGS2PTGS1
SCHEMBL1050359 0.87 PTGDR2 (0.39) ENPP2KCNK3PTGDR2CYP1A2CYP3A4
SCHEMBL1050361 0.87 PTGDR2 (0.39) ENPP2KCNK3PTGDR2CYP1A2CYP3A4
SCHEMBL5321729 0.86 ENPP2 (0.38) ENPP2KCNK3PTGDR2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed